In vitro release of fusidic acid and teicoplanin from cancellous bone allografts.
The characteristics of cancellous bone allografts as carriers of fusidic acid and teicoplanin are described. Particles of cancellous bone were compressed into a wiremesh cylinder; five replicas were impregnated for one hour into fusidic acid; and another five for one hour into teicoplanin. Elution was estimated daily. Concentrations of fusidic acid and teicoplanin were determined by a microbiological assay. Both antibiotics were eluted at very high concentrations within the first days. Allografts impregnated in fusidic acid provided concentrations above 20 microg/ml for 20 days. Eluted teicoplanin after day 4 was below 10 microg/ml. It is concluded that cancellous bone allografts may allow adequate in vitro elution of fusidic acid but not of teicoplanin. The latter results support their application in experimental models of osteomyelitis.
Kanellakopoulou
K
K
4th Department of Internal Medicine, University of Athens, Greece.
Sahinides
T
T
Tsaganos
T
T
Galanakis
N
N
Giamarellou
H
H
Giamarellos-Bourboulis
E J
EJ
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001842:Bone and Bones; D004337:Drug Carriers; D005672:Fusidic Acid / Q000008:administration & dosage*; D006801:Humans; D066298:In Vitro Techniques; D017334:Teicoplanin / Q000008:administration & dosage*; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D004337:Drug Carriers; D005672:Fusidic Acid; D017334:Teicoplanin